Email This Article
Headlines & Perspectives
How to Review Biotech Clinical Data
By
Adam Feuerstein
04/17/08 - 10:54 AM EDT
If you can spot red flags in data presentations, you can avoid getting suckered into biotech money traps.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,431.07 | 1,102.93 | 2,183.68 | 35.67 |
Oil *
71.14
|
|
UP
25.24
|
UP
0.58
|
DOWN
7.18
|
UP
0.85
|
10 Yr
3.57%
SPDR Gold
108.95
|
|
+0.24%
|
+0.05%
|
-0.33%
|
+2.44%
|
Data delayed 20 minutes |


Connect with TheStreet